Related News
Drug companies involved in bribery and tax evasion
By Jane Chen |
August 21, 2009, Friday
|
Online Edition
Online Edition
A PARMACEUTICAL industry insider has called on the government to crack down on the industry, which he says is rife with bribery, money laundering and tax evasion, resulting in higher costs of medicines.
Lu Tao, who has worked 10 years in the industry, with four as a drug sales representative, disclosed it in today's China Youth Daily.
Under Chiona's rules governing drug sales, companies must tell the drug authority the cost of making the drugs before supplying them to hospitals and other businesses. Hospitals then sell them to patients for no more than 15 percent more than their supply prices.
But in practice, drug companies quote much higher costs to make more profit, Lu said.
Lu cited an unnamed drug as an example, saying it cost 26 yuan (US$3.80) a bottle to produce but told the authority it cost 189 yuan.
To get hospitals to use their drugs, sales representatives usually bribe hospital staff, from the principal to the frontline doctors, Lu added.
It has become normal practice for sales people to give money equivalent to 20-35 percent of the drug prices to doctors to encourage them to use their products, he disclosed.
Hospitals would suspend buying a drug if it is not prescribed for three months, according to the drug management rule. To make a suspended drug re-enter a hospital is nearly impossible, he explained.
The industry is also involved in tax evasion, Lu claimed.
Some companies sell drugs to a third party at higher prices before forwarding them to hospitals to get higher tax rebates, he said.
Lu Tao, who has worked 10 years in the industry, with four as a drug sales representative, disclosed it in today's China Youth Daily.
Under Chiona's rules governing drug sales, companies must tell the drug authority the cost of making the drugs before supplying them to hospitals and other businesses. Hospitals then sell them to patients for no more than 15 percent more than their supply prices.
But in practice, drug companies quote much higher costs to make more profit, Lu said.
Lu cited an unnamed drug as an example, saying it cost 26 yuan (US$3.80) a bottle to produce but told the authority it cost 189 yuan.
To get hospitals to use their drugs, sales representatives usually bribe hospital staff, from the principal to the frontline doctors, Lu added.
It has become normal practice for sales people to give money equivalent to 20-35 percent of the drug prices to doctors to encourage them to use their products, he disclosed.
Hospitals would suspend buying a drug if it is not prescribed for three months, according to the drug management rule. To make a suspended drug re-enter a hospital is nearly impossible, he explained.
The industry is also involved in tax evasion, Lu claimed.
Some companies sell drugs to a third party at higher prices before forwarding them to hospitals to get higher tax rebates, he said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
